Corona medication in phase III study could be available soon

Novartis and the US pharma corporation Incyte are planning to test their Corona medication Jakavi in a phase III study. Phase III studies are on humans. Jakavi should assuate the cytokine storm a type of severe immune overreaction that can result from corona infection and may contribute to respiratory compromise in patients with corona infection and should expedite the recovery.

Phase III study means that the medication could soon be available for patients to buy.



Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.